Assenagon Asset Management S.A. Cuts Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Assenagon Asset Management S.A. cut its position in Addus HomeCare Co. (NASDAQ:ADUS) by 33.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 72,283 shares of the company’s stock after selling 36,031 shares during the period. Assenagon Asset Management S.A. owned approximately 0.40% of Addus HomeCare worth $9,061,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Wasatch Advisors LP increased its holdings in shares of Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after purchasing an additional 110,010 shares in the last quarter. Point72 Asset Management L.P. boosted its position in shares of Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after buying an additional 315,602 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after buying an additional 5,421 shares in the last quarter. State Street Corp raised its position in Addus HomeCare by 4.4% in the 3rd quarter. State Street Corp now owns 663,610 shares of the company’s stock worth $88,280,000 after buying an additional 27,990 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its stake in Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after acquiring an additional 75,409 shares during the period. Institutional investors own 95.35% of the company’s stock.

Insider Transactions at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Stock Performance

Shares of ADUS opened at $133.87 on Friday. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.12. The company’s fifty day moving average is $125.28 and its 200 day moving average is $126.53. The stock has a market capitalization of $2.43 billion, a PE ratio of 30.63, a P/E/G ratio of 1.63 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.03 EPS. As a group, research analysts forecast that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Macquarie reaffirmed an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. StockNews.com lowered Addus HomeCare from a “buy” rating to a “hold” rating in a report on Thursday. JMP Securities started coverage on Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price on the stock. Oppenheimer boosted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Finally, KeyCorp started coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $133.67.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.